Naturally Occurring Mutations in the Melanocortin Receptor 3 Gene Are Not Associated with Type 2 Diabetes Mellitus in French Caucasians1
El Habib Hani,
Sophie Dupont,
Emmanuelle Durand,
Christian Dina,
Sophie Gallina,
Ira Gantz and
Philippe Froguel
Lille Institute of Biology-Centre National de la Recherche
Scientifique 8090 and Lille Pasteur Institute (E.H.H., S.D., E.D.,
C.D., S.G., P.F.), 59000 Lille, France; and University of Michigan
Medical School (I.G.), Ann Arbor, Michigan 48109
Address all correspondence and requests for reprints to: Prof. Philippe Froguel, Institut Pasteur de Lille, 1 rue du Pr Calmette 59000 Lille, France. E-mail: froguel{at}mail-good.pasteur-lille.fr
Abstract
Familial genetic studies of type 2 diabetes (T2DM) of differenthuman
populations, including the French Caucasians, suggestedevidence for
linkage of T2DM and human chromosome 20q13, a regionwhere maps the
melanocortin 3 receptor gene (MC3R). Likewise,its
homologous MC4R in human obesity, MC3R
gene is also a goodcandidate for genetic susceptibility to glucose
intoleranceand T2DM. We therefore undertook a molecular study to
assessthe role of genetic variations of this gene in a large cohortof
French families with T2DM. In these patients, we identifiedtwo
missense mutations in the MC3R gene:
Val81Ile and Lys6Thr.These two variants, which
were in complete linkage disequilibrium,were also present in
nondiabetic controls. Based on associationand familial linkage
disequilibrium tests results, we foundthat these MC3R
gene-coding variants were not associated withdiabetes or obesity.
These variants were found, however, marginallyassociated with insulin
and glucose levels during oral glucosetolerance testing in
normoglycemic subjects. Overall, the presentstudy provides no evidence
for a major role of the MC3R codingmutations underlying
the genetic linkages of T2DM and the MC3Rgene region on
chromosome 20q13 in T2DM families from Franceand other geographical
origins.
This article has been cited by other articles:
D. M Savastano, M. Tanofsky-Kraff, J. C Han, C. Ning, R. A Sorg, C. A Roza, L. E Wolkoff, K. Anandalingam, K. S Jefferson-George, R. E Figueroa, et al. Energy intake and energy expenditure among children with polymorphisms of the melanocortin-3 receptor
Am. J. Clinical Nutrition,
October 1, 2009;
90(4):
912 - 920.
[Abstract][Full Text][PDF]
M. A. Calton, B. A. Ersoy, S. Zhang, J. P. Kane, M. J. Malloy, C. R. Pullinger, Y. Bromberg, L. A. Pennacchio, R. Dent, R. McPherson, et al. Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study
Hum. Mol. Genet.,
March 15, 2009;
18(6):
1140 - 1147.
[Abstract][Full Text][PDF]
Y. Seng Lee, L. Kok Seng Poh, B. Lay Kee Kek, and K. Yin Loke The Role of Melanocortin 3 Receptor Gene in Childhood Obesity
Diabetes,
October 1, 2007;
56(10):
2622 - 2630.
[Abstract][Full Text][PDF]
N. Santoro, L. Perrone, G. Cirillo, P. Raimondo, A. Amato, C. Brienza, and E. M. del Giudice Effect of the melanocortin-3 receptor C17A and G241A variants on weight loss in childhood obesity
Am. J. Clinical Nutrition,
April 1, 2007;
85(4):
950 - 953.
[Abstract][Full Text][PDF]
J. Rutanen, J. Pihlajamaki, M. Vanttinen, U. Salmenniemi, E. Ruotsalainen, T. Kuulasmaa, S. Kainulainen, and M. Laakso Single Nucleotide Polymorphisms of the Melanocortin-3 Receptor Gene Are Associated with Substrate Oxidation and First-Phase Insulin Secretion in Offspring of Type 2 Diabetic Subjects
J. Clin. Endocrinol. Metab.,
March 1, 2007;
92(3):
1112 - 1117.
[Abstract][Full Text][PDF]
L. K. Phan, W. K. Chung, and R. L. Leibel The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity
Am J Physiol Endocrinol Metab,
September 1, 2006;
291(3):
E611 - E620.
[Abstract][Full Text][PDF]
N. Feng, S. F. Young, G. Aguilera, E. Puricelli, D. C. Adler-Wailes, N. G. Sebring, and J. A. Yanovski Co-occurrence of Two Partially Inactivating Polymorphisms of MC3R Is Associated With Pediatric-Onset Obesity
Diabetes,
September 1, 2005;
54(9):
2663 - 2667.
[Abstract][Full Text][PDF]
Y.-X. Tao and D. L. Segaloff Functional Characterization of Melanocortin-3 Receptor Variants Identify a Loss-of-Function Mutation Involving an Amino Acid Critical for G Protein-Coupled Receptor Activation
J. Clin. Endocrinol. Metab.,
August 1, 2004;
89(8):
3936 - 3942.
[Abstract][Full Text][PDF]
A. P. Coll, I. S. Farooqi, B. G. Challis, G. S. H. Yeo, and S. O'Rahilly Proopiomelanocortin and Energy Balance: Insights from Human and Murine Genetics
J. Clin. Endocrinol. Metab.,
June 1, 2004;
89(6):
2557 - 2562.
[Abstract][Full Text][PDF]